"Being the practice that starts next week, instead of next month, is the most powerful marketing tool in oncology."
Field note from a regional referral build
Speed is a clinical and emotional imperative.
In oncology, time matters in two ways. Clinically, every week of delay is a week of disease progression and patient anxiety. Strategically, the practice that can start treatment first usually wins the case.
At a major academic center, the path from initial referral to the first treatment session can stretch to six or eight weeks. Fragmented scheduling, committee-based approvals, and a high volume of rare cases clog the system. A streamlined regional referral-to-sim workflow can start patients in under ten days.
- Single point of intake. A nurse navigator who owns the referral from the moment it arrives, with explicit time-to-consult and time-to-sim service levels.
- Compressed simulation. Same-week consult, sim, and contour. No queue behind a teaching service or a rotating fellow.
- Transparent expectations. Tell the patient and the referring physician on day one when treatment will start. Then meet that date.
Patient experience is a clinical asset.
The AMC experience often involves a parking garage, a long walk through confusing corridors, and a different resident at every visit. A regional facility can offer something the AMC structurally cannot: a front door experience.
- Familiarity. Patients see the same therapists and physicists every day. This consistency is what builds the trust required to manage the side effects of a complex radiation course.
- Logistics. Front-door parking and suburban locations remove the physical and mental friction of treatment, especially in weeks four and five.
- Throughput vs. flow. AMCs are designed for volume. A regional practice is designed for flow. A material reduction in wait-room time relative to the local university hospital is a metric that referring physicians and patients both notice.
Strategic referring physician relationships.
Referral patterns are built on trust and feedback. Academic centers are notorious for losing patients in their system. Once a patient is referred to an AMC, the community urologist or surgeon often stops receiving updates. Your competitive edge is the closed feedback loop.
- Immediate intake. Notify the referring physician the moment the patient is scheduled.
- Live updates. Provide a portal or a direct line for real-time treatment status, not a fax three weeks after the fact.
- The hand-back. Explicitly transition the patient back to the referring physician the moment the radiation course is complete. You are a partner, not a competitor.
Referral received
Day 0 · 09:14
Patient contacted, consult booked
Day 0 · 14:02
Consult complete · plan: 5-fraction SBRT
Day 2
Simulation and contouring complete
Day 4
First treatment delivered
Day 7
Course complete · hand-back to referring MD
Day 12
Pick your battles. Buy what your market lacks.
You do not need every piece of equipment in the catalog. You need the technology your local market lacks. Three investments tend to clear the ROI hurdle for a regional practice without committing to a one hundred and fifty million dollar proton vault.
- Specialized SBRT and SRS. A LINAC optimized for high-dose, short-course treatments of lung and brain disease. You can treat high-acuity cases at a fraction of the capital cost of a proton beam.
- Theranostics and RPT. A dedicated hot lab for radiopharmaceuticals lets you capture the metastatic market that AMCs often struggle to manage efficiently.
- Advanced PET/CT. High-resolution imaging is the engine of radiation oncology. The best scanner in a fifty-mile radius makes you the diagnostic gold standard for your local peers.
| Investment | CAPEX | Utilization | Payback | Profile |
|---|---|---|---|---|
| Specialized SBRT/SRS LINAC | $4–6M | High | 3–4 yrs | Efficiency |
| Theranostics hot lab | $1.5–3M | High | 2–3 yrs | Efficiency |
| Advanced PET/CT | $2–3M | High | 3–5 yrs | Efficiency |
| Single-room proton vault | $40–60M | Moderate | 10–15 yrs | Prestige |
| Multi-room proton center | $120–180M | Variable | 15+ yrs | Prestige |
Own the bread and butter.
Do not try to be the world leader in rare pediatric neuroblastoma. Be the undisputed regional expert in the three sites that drive most radiation volume: prostate, breast, and lung.
Build a center of excellence around each of these indications. Optimize the workflow, hire specialized nurses, and market directly to the local population. When someone in your county is diagnosed with breast cancer, your name should be the first one their primary care physician mentions, not a hedged alternative to the university hospital.
| Dimension | Academic medical center | Regional practice |
|---|---|---|
| Decision speed | Months · committee-based | Days · partnership |
| Patient access | 6–8 weeks to first treatment | 1–2 weeks to first treatment |
| Parking and entry | Central garage · long walk | Front door · suburban site |
| Provider continuity | Rotational · residents and fellows | Consistent · same MD and staff |
| Referring physician feedback | Low · fragmented | High · direct loop |
Agility is the asset the AMC cannot buy.
The AMC will always have more grant money and more letterhead. What it does not have is the ability to make a decision in a week, start a patient in ten days, and call the referring doctor on day one. Those are the assets a regional radiation oncology practice already owns. The question is whether the operating model is built to use them.
A note on the numbers
Time-to-treatment ranges, ROI estimates, and operational benchmarks are operator-grade approximations drawn from public references and our own advisory engagements. They are intended to frame the strategic conversation, not to substitute for a site-specific market and feasibility analysis.